
### [NCIT:C4525](http://purl.obolibrary.org/obo/NCIT_C4525)
**Label:** Kidney Sarcoma

**Subclasses:** [NCIT:C7726](http://purl.obolibrary.org/obo/NCIT_C7726) (Kidney Fibrosarcoma), [NCIT:C6181](http://purl.obolibrary.org/obo/NCIT_C6181) (Kidney Extraskeletal Osteosarcoma), [NCIT:C6183](http://purl.obolibrary.org/obo/NCIT_C6183) (Kidney Leiomyosarcoma), [NCIT:C4264](http://purl.obolibrary.org/obo/NCIT_C4264) (Clear Cell Sarcoma of the Kidney), [NCIT:C6185](http://purl.obolibrary.org/obo/NCIT_C6185) (Kidney Liposarcoma), 

**Class expressions from DL-Learner:**

- Thing 52.77%
- [NCIT:C12964](http://purl.obolibrary.org/obo/NCIT_C12964) (Connective and Soft Tissue) 39.96%
- [NCIT:C45714](http://purl.obolibrary.org/obo/NCIT_C45714) (Epithelial Tissue) 39.52%
- [NCIT:C45714](http://purl.obolibrary.org/obo/NCIT_C45714) (Epithelial Tissue) and (not ([NCIT:C38373](http://purl.obolibrary.org/obo/NCIT_C38373) (RBM15-MKL1 Fusion Protein Expression))) 39.52%
- [NCIT:C45714](http://purl.obolibrary.org/obo/NCIT_C45714) (Epithelial Tissue) and (not ([NCIT:C38372](http://purl.obolibrary.org/obo/NCIT_C38372) (CEBPA Gene Mutation))) 39.52%
- [NCIT:C45714](http://purl.obolibrary.org/obo/NCIT_C45714) (Epithelial Tissue) and (not ([NCIT:C38362](http://purl.obolibrary.org/obo/NCIT_C38362) (RUNX1 Gene Mutation))) 39.52%
- [NCIT:C45714](http://purl.obolibrary.org/obo/NCIT_C45714) (Epithelial Tissue) and (not ([NCIT:C3836](http://purl.obolibrary.org/obo/NCIT_C3836) (Infertility))) 39.52%
- [NCIT:C45714](http://purl.obolibrary.org/obo/NCIT_C45714) (Epithelial Tissue) and (not ([NCIT:C38350](http://purl.obolibrary.org/obo/NCIT_C38350) (del(4)(q12)))) 39.52%
- [NCIT:C45714](http://purl.obolibrary.org/obo/NCIT_C45714) (Epithelial Tissue) and (not ([NCIT:C38348](http://purl.obolibrary.org/obo/NCIT_C38348) (MSN-ALK Fusion Protein Expression))) 39.52%
- [NCIT:C45714](http://purl.obolibrary.org/obo/NCIT_C45714) (Epithelial Tissue) and (not ([NCIT:C38347](http://purl.obolibrary.org/obo/NCIT_C38347) (P13K-AKT Pathway Deregulation))) 39.52%
- [NCIT:C45714](http://purl.obolibrary.org/obo/NCIT_C45714) (Epithelial Tissue) and (not ([NCIT:C38346](http://purl.obolibrary.org/obo/NCIT_C38346) (MYC Pathway Deregulation))) 39.52%
- [NCIT:C45714](http://purl.obolibrary.org/obo/NCIT_C45714) (Epithelial Tissue) and (not ([NCIT:C38345](http://purl.obolibrary.org/obo/NCIT_C38345) (JUN Pathway Deregulation))) 39.52%
- [NCIT:C45714](http://purl.obolibrary.org/obo/NCIT_C45714) (Epithelial Tissue) and (not ([NCIT:C38344](http://purl.obolibrary.org/obo/NCIT_C38344) (RAS-RAF Pathway Deregulation))) 39.52%
- [NCIT:C45714](http://purl.obolibrary.org/obo/NCIT_C45714) (Epithelial Tissue) and (not ([NCIT:C38343](http://purl.obolibrary.org/obo/NCIT_C38343) (JAK-STAT Pathway Deregulation))) 39.52%
- [NCIT:C45714](http://purl.obolibrary.org/obo/NCIT_C45714) (Epithelial Tissue) and (not ([NCIT:C38341](http://purl.obolibrary.org/obo/NCIT_C38341) (Postgerminal Center B-Lymphocyte of Unknown Differentiation Stage))) 39.52%


